查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2030051

空間基因組學和轉錄組學市場－全球產業規模、佔有率、趨勢、機會、預測：按技術、產品類型、應用、最終用戶、地區和競爭格局分類，2021-2031年

Spatial Genomics and Transcriptomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technique, By Product Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球太空基因組學和轉錄組學市場預計將從 2025 年的 10.3 億美元成長到 2031 年的 21.2 億美元，複合年成長率為 12.78%。

該市場涵蓋旨在分析生物樣本分子組成並同時保持其原始空間結構的最尖端科技，從而獲取完整組織中細胞功能的關鍵資訊。該領域的成長主要受慢性病和複雜疾病盛行率上升、精準醫療需求日益成長以及基礎生物學調查方法不斷進步的驅動。這些因素共同推動了能夠以高空間精度解碼複雜生物活性的先進儀器的應用。

市場概覽
預測期 2027-2031
市場規模：2025年 10.3億美元
市場規模：2031年 21.2億美元
複合年成長率：2026-2031年 12.78%
成長最快的細分市場 軟體
最大的市場 北美洲

根據美國人類遺傳學會2024-2025年度報告，人類遺傳學和基因組學相關期刊的投稿量預計將成長約50%，顯示該領域基礎研究穩步發展，且參與度較高。儘管發展勢頭良好，但市場仍面臨一個重大障礙：空間基因組學和轉錄組學所需的設備和相關試劑的初始投資較高。這項經濟門檻可能會阻礙該技術的廣泛應用，尤其是在預算有限的小規模研究機構中。

市場促進因素

空間分析技術的進步正成為全球太空基因組學和轉錄組學市場的主要成長引擎，它提高了保存組織中分子評估的準確性和範圍。持續的創新不斷突破資料擷取和影像解析度的極限，為更深入地理解複雜的生物網路打開了大門。例如，2025年2月，Illumina公司宣布了一項突破性的太空技術舉措捕獲面積擴大了9倍，解析度提高了4倍，從而能夠對複雜組織進行大規模成像。這種技術進步將使科學家能夠更精確地揭示細胞間通訊和疾病通路，提供豐富的背景訊息，這些資訊對於個人化醫療和藥物研發至關重要。

空間基因組學和轉錄組學研發投入的增加也是推動市場發展的主要因素。此類資金支持加速了新軟體、試劑和分析工具的開發，從而擴大了市場規模和功能。例如，Vizgen公司在2026年1月發布的新聞稿中宣布，已成功完成由ARCH Venture Partners主導的4,800萬美元資金籌措，旨在拓展公司的全球企業發展和平台能力。除了商業和研究活動的加強之外，學術成果的快速成長——尤其是自2024年底以來，已有超過100篇具有影響力的同行評審論文使用Vizgen的MERSCOPE平台發表——也表明空間生物學方法在科學界的認可度和檢驗正在不斷提高。

市場挑戰

全球空間基因組學和轉錄組學市場面臨一個重大障礙：購置專用設備和相關試劑需要大量的初始投資。這種高昂的進入門檻限制了科技的傳播和應用，尤其對預算有限的新興機構和小規模研究中心造成了嚴重影響。因此，由於獲取關鍵的最尖端科技成本高昂，這些資金限制阻礙了創新加速和研究範圍的擴大。

當前嚴峻的經濟情勢加劇了這個問題，整個生技產業都深受其害。正如生物產業協會的報告《2025年英國生技融資》中所述，預計到2025年，英國生技領域的資金籌措創業投資前一年下降13.2%。可用資金的減少進一步阻礙了那些尋求籌集昂貴空間基因組學和轉錄組學系統所需巨額資金的機構，最終阻礙了市場擴張，並妨礙了這些強大的工具無縫整合到各種研究環境中。

市場趨勢

為了更好地解讀空間基因組學和轉錄組學系統產生的複雜高維度訊息，業界正日益依賴機器學習和人工智慧。這些先進的計算技術使科學家能夠快速處理大量數據，識別複雜的細胞行為，並得出對加速研究和理解疾病路徑至關重要的深刻生物學結論。 Benchling 發布的 2026 年 2 月生物技術人工智慧報告支持了這一轉變，報告指出，80% 的公司計劃在未來一年增加對人工智慧的投資，預計這些資金將用於增強科學建模和數據基礎設施。人工智慧與空間生物學的融合對於將原始數據轉化為可操作的洞見至關重要，從而推動精準醫療和新型治療方法的開發。

另一個值得關注的趨勢是空間基因組學和轉錄組學正穩步從基礎研究工具發展成為臨床層級分析解決方案。這一趨勢的目標是建立檢驗的標準化流程，用於患者選擇、診斷應用和個人化治療方案的設計。對來自完整組織的精確分子數據的需求，以指南臨床決策，正推動這項技術超越傳統學術框架的擴展。為了凸顯這一向轉化應用的轉變，BMKGENE於2026年4月宣佈設立“2026年空間轉錄組學卓越獎”，承諾提供15萬歐元，用於支持22項免費的空間轉錄組學服務，以促進轉化研究。此類計畫有助於檢驗和推廣這些先進工具，使其能夠應用於臨床實踐，最終加速對醫療保健成果的正面影響。

目錄

第1章 產品概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球空間基因體學與轉錄組學市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 透過科技（空間轉錄組學、空間基因組學分析）
    • 依產品類型（設備、耗材、軟體）
    • 按應用領域（轉化研究、藥物發現和藥物開發）
    • 按最終用戶（製藥和生物技術公司、合約研究組織、學術和研究機構）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美空間基因體學與轉錄組學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲空間基因體學與轉錄組學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區空間基因體學與轉錄組學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲太空基因組學和轉錄組學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲空間基因體學與轉錄組學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球空間基因體學與轉錄組學市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • 10X Genomics Inc.
  • Akoya Bioscience Ltd.
  • Biospyder Technologies Inc.
  • BioTechne Corporation
  • Dovetail Genomics LLC
  • Fluidigm Corporation
  • Genomic Vision SA
  • Illumina Inc.
  • Lunaphore Technologies SA
  • Nanostring Technologies Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 15176

The Global Spatial Genomics and Transcriptomics Market is expected to expand from USD 1.03 billion in 2025 to USD 2.12 billion by 2031, reflecting a compound annual growth rate of 12.78%. This market includes cutting-edge technologies designed to profile the molecular makeup of biological samples while maintaining their original spatial structure, thereby yielding vital information regarding cellular functions in intact tissues. The growth of this sector is largely propelled by the rising incidence of chronic and complex illnesses, an increasing need for precision medicine, and continuous improvements in basic biological research methodologies. Together, these elements drive the uptake of advanced instruments that can decode complex biological activities with high spatial precision.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.03 Billion
Market Size 2031USD 2.12 Billion
CAGR 2026-203112.78%
Fastest Growing SegmentSoftware
Largest MarketNorth America

The American Society of Human Genetics' 2024-2025 Annual Report highlights an estimated 50% rise in journal submissions related to human genetics and genomics, demonstrating robust progress and activity in foundational research tied to this industry. Despite this positive momentum, the market faces a major obstacle in the form of high upfront capital costs needed for spatial genomics and transcriptomics equipment and their corresponding reagents. This financial hurdle can restrict broad accessibility and uptake, especially among smaller research facilities with limited budgets.

Market Driver

Technological improvements in spatial analysis act as a key growth engine for the Global Spatial Genomics and Transcriptomics Market by improving the accuracy and breadth of molecular evaluations in preserved tissues. Continuous innovations extend the limits of data collection and image resolution, paving the way for a deeper comprehension of intricate biological networks. As an example, in February 2025, Illumina, Inc. introduced a novel spatial technology initiative offering a capture area nine times larger and a resolution four times higher than prior methods, enabling the large-scale mapping of complex tissues. This level of technological evolution empowers scientists to reveal detailed cellular communications and disease pathways more accurately, yielding rich contextual information that benefits personalized medicine and drug development.

Growing research and development funding allocated to spatial genomics and transcriptomics also serves as a major market driver. Such financial support accelerates the creation of new software, reagents, and analytical tools, subsequently broadening the market's reach and functional capacity. For example, a January 2026 press release from Vizgen, Inc. reported the successful closure of a $48 million funding round spearheaded by ARCH Venture Partners, aimed at expanding the company's global footprint and platform capabilities. In addition to bolstering commercial and research endeavors, the rapid increase in academic output-highlighted by over 100 new high-impact, peer-reviewed papers using Vizgen's MERSCOPE platform since late 2024-illustrates the escalating acceptance and verification of spatial biology methods across the scientific landscape.

Market Challenge

The Global Spatial Genomics and Transcriptomics Market encounters a notable obstacle due to the heavy upfront capital needed to purchase specialized equipment and its related reagents. This steep cost of entry restricts widespread adoption and access, disproportionately affecting emerging organizations and smaller research centers that function on tight budgets. Consequently, these financial constraints hinder the acceleration of innovation and the broadening of research scopes, as securing the vital, cutting-edge technology proves to be cost-prohibitive.

This problem is compounded by a difficult economic climate currently affecting the wider biotechnology industry. As noted in the BioIndustry Association's 'UK Biotech Financing 2025' report, venture capital funding within the UK biotech arena dropped by 13.2% in 2025 relative to the prior year. This decline in accessible funds creates additional hurdles for institutions attempting to raise the substantial capital required for expensive spatial genomics and transcriptomics systems, ultimately stifling market expansion and preventing the seamless incorporation of these robust tools into diverse research environments.

Market Trends

To better interpret the intricate, high-dimensional information produced by spatial genomics and transcriptomics systems, the industry is increasingly turning to machine learning and artificial intelligence. These sophisticated computational methods allow scientists to quickly process massive amounts of data, spot complex cellular behaviors, and draw profound biological conclusions that are essential for speeding up research and comprehending disease pathways. Highlighting this shift, Benchling's February 2026 Biotech AI Report indicates that 80 percent of companies intend to boost their AI spending over the coming year, directing these funds toward improved scientific modeling and data infrastructure. Merging AI with spatial biology is crucial for turning raw metrics into practical insights that shape precision medicine and the creation of new therapeutics.

A further notable trend is the steady evolution of spatial genomics and transcriptomics from basic research instruments into clinical-grade profiling solutions. The goal of this movement is to create verified, standardized procedures for patient sorting, diagnostic applications, and the design of personalized treatments. Demand for accurate molecular data from intact tissues to guide clinical decisions is driving this expansion beyond traditional academic settings. Highlighting this shift toward translational applications, BMKGENE revealed its 2026 Spatial Transcriptomics Excellence Award in April 2026, pledging €150,000 to fund 22 free spatial transcriptomics services for translational studies. Programs like this promote the validation and availability required to integrate these advanced tools into clinical environments, ultimately hastening their positive effect on healthcare outcomes.

Key Market Players

  • 10X Genomics Inc.
  • Akoya Bioscience Ltd.
  • Biospyder Technologies Inc.
  • BioTechne Corporation
  • Dovetail Genomics LLC
  • Fluidigm Corporation
  • Genomic Vision SA
  • Illumina Inc.
  • Lunaphore Technologies SA
  • Nanostring Technologies Inc.

Report Scope

In this report, the Global Spatial Genomics and Transcriptomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Spatial Genomics and Transcriptomics Market, By Technique

  • Spatial Transcriptomics
  • Spatial Genomics Analysis

Spatial Genomics and Transcriptomics Market, By Product Type

  • Instruments
  • Consumables
  • Software

Spatial Genomics and Transcriptomics Market, By Application

  • Translational Research
  • Drug discovery & development

Spatial Genomics and Transcriptomics Market, By End User

  • Pharmaceutical & Biotechnology companies
  • Contract Research Organizations
  • Academic & Research Institutes

Spatial Genomics and Transcriptomics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Spatial Genomics and Transcriptomics Market.

Available Customizations:

Global Spatial Genomics and Transcriptomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Spatial Genomics and Transcriptomics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (Spatial Transcriptomics, Spatial Genomics Analysis)
    • 5.2.2. By Product Type (Instruments, Consumables, Software)
    • 5.2.3. By Application (Translational Research, Drug discovery & development)
    • 5.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Spatial Genomics and Transcriptomics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By Product Type
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Spatial Genomics and Transcriptomics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technique
        • 6.3.1.2.2. By Product Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Spatial Genomics and Transcriptomics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technique
        • 6.3.2.2.2. By Product Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Spatial Genomics and Transcriptomics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technique
        • 6.3.3.2.2. By Product Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Spatial Genomics and Transcriptomics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Product Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Spatial Genomics and Transcriptomics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. France Spatial Genomics and Transcriptomics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Spatial Genomics and Transcriptomics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Spatial Genomics and Transcriptomics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technique
        • 7.3.4.2.2. By Product Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Spatial Genomics and Transcriptomics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technique
        • 7.3.5.2.2. By Product Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia Pacific Spatial Genomics and Transcriptomics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Product Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Spatial Genomics and Transcriptomics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Spatial Genomics and Transcriptomics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Spatial Genomics and Transcriptomics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Spatial Genomics and Transcriptomics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technique
        • 8.3.4.2.2. By Product Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Spatial Genomics and Transcriptomics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technique
        • 8.3.5.2.2. By Product Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Middle East & Africa Spatial Genomics and Transcriptomics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Product Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Spatial Genomics and Transcriptomics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Spatial Genomics and Transcriptomics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Spatial Genomics and Transcriptomics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Spatial Genomics and Transcriptomics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique
    • 10.2.2. By Product Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Spatial Genomics and Transcriptomics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Spatial Genomics and Transcriptomics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Spatial Genomics and Transcriptomics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Spatial Genomics and Transcriptomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. 10X Genomics Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Akoya Bioscience Ltd.
  • 15.3. Biospyder Technologies Inc.
  • 15.4. BioTechne Corporation
  • 15.5. Dovetail Genomics LLC
  • 15.6. Fluidigm Corporation
  • 15.7. Genomic Vision SA
  • 15.8. Illumina Inc.
  • 15.9. Lunaphore Technologies SA
  • 15.10. Nanostring Technologies Inc.

16. Strategic Recommendations

17. About Us & Disclaimer